Why the study?
Hypertrophic cardiomyopathy can be clinically silent and present with sudden death as its initial manifestation, leaving the association between reported physical symptoms and suspected disease unclear.
Are reported physical symptoms associated with the presence of suspected hypertrophic cardiomyopathy during screening echocardiography?
Are reported physical symptoms associated with the presence of suspected hypertrophic cardiomyopathy during screening echocardiography?
Reported physical symptoms are not associated with the presence of suspected hypertrophic cardiomyopathy, highlighting that HCM is often asymptomatic and cannot be reliably screened via questionnaire alone.
Answers are grounded in this paper and cite their sources.
Symptoms unreliable for suspected HCM detection; leaves open whether questionnaires add value to imaging screening.
Background: The prevalence of hypertrophic cardiomyopathy (HCM) can be silent and can present with sudden death as the first manifestation of this disease. The goal of this study was to evaluate any association between reported physical symptoms with the presence of suspected HCM. Method: The Anthony Bates Foundation has been performing screening echocardiography across the United States for the prevention of sudden death since 2001. A total of 4,120 subjects between the ages of 6 and 79 underwent echocardiographic screening. We evaluated any association between any symptoms and suspected HCM defined as any left ventricular wall thickness ≥ 15 mm. Results: The total prevalence of suspected HCM in the entire study population was 1.1%. The presence of physical symptoms were not associated with HCM (chest pain in 4.3% of participant with HCM vs. 9.9% of the control, p=0.19, palpitation in 4.3% of participant with HCM vs. 7.3% of the control., p=0.41, shortness of breath in 6.4% of participant with HCM vs. 11.7% of the control., p=0.26, lightheadedness in 4.3% of participant with HCM vs. 13.1% of the control., p=0.07, ankle swelling in 2.1% of participant with HCM vs. 4.0% of the control., p=0.52, dizziness in 8.5% of participant with HCM vs. 12.2% of the control., p=0.44). Conclusion: Echocardiographic presence of suspected HCM is not associated with a higher prevalence of physical symptoms in the participants undergoing screening echocardiography. This finding confirmed that HCM can be asymptomatic in many patients and a questionnaire cannot distinguish the HCM population from a control group.
No takes yet. Share an insight, caveat, or question.
Movahed et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: